Exploratory secondary analysis of a phase 1 trial in 46 adults: a bivalent Vi-CRM197 + O:2 CRM197 vaccine induced anti-O:2 IgA/IgM and bactericidal activity against diverse Paratyphi A isolates; day-29 IgA rose 74.14-fold without alum vs 16.65-fold with alum.
Secondary analysisn = 46
Carducci et al. Immunogenicity of a Bivalent Typhoid-Paratyphoid Conjugate Vaccine Against Diverse Salmonella Paratyphi A Isolates